This hypothesis was formed when three pieces of information were stacked: first, severe COVID-19 patients were often accompanied by a significant elevation of cytokines such as interleukin-6, interleukin-10 and tumour necrosis factor α. Second, catecholamines augmented the production of those cytokines in vitro and mice. This evidence concerns the gene IL10 and COVID-19.